Cécile Chartier
Impact in
Papers in
- Co-authors
- Annick Dieterle (4 shared papers)Andréa Pavirani (4 shared papers)Majid Mehtali (4 shared papers)Eric Degryse (2 shared papers)Murielle Gantzer (1 shared paper)John A. Lewicki (2 shared papers)Austin L. Gurney (2 shared papers)Michael F. Clarke (1 shared paper)
- Journals
- Annals of Oncology (3 papers)PLoS ONE (2 papers)Clinical Cancer Research (1 paper)Nature Medicine (1 paper)Science Advances (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Cécile Chartier
19 papers receiving 2.5k citations
Cécile Chartier's Hit Papers
Peers
Comparison fields: 5 of 74
- Oncology 917
- Genetics 710
- Molecular Biology 748
- Immunology 169
- Cancer Research 87
Countries citing papers authored by Cécile Chartier
This map shows the geographic impact of Cécile Chartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cécile Chartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cécile Chartier more than expected).
Fields of papers citing papers by Cécile Chartier
This network shows the impact of papers produced by Cécile Chartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cécile Chartier. The network helps show where Cécile Chartier may publish in the future.
Co-authors
The 25 scholars most cited alongside Cécile Chartier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 604 | |
| 2 | 2012 | 527 | |
| 3 | 2008 | 496 | |
| 4 | Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma Hit paper breakdown → | 2021 | 328 |
| 5 | 2008 | 171 | |
| 6 | 2006 | 144 | |
| 7 | 2017 | 128 | |
| 8 | 2016 | 99 | |
| 9 | Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. | 1996 | 57 |
| 10 | Targeting cell-specific gene expression with an adenovirus vector containing the lacZ gene under the control of the CFTR promoter. | 1996 | 32 |
| 11 | An efficient procedure to select and recover recombinant adenovirus vectors. | 1995 | 26 |
| 12 | 2020 | 16 | |
| 13 | The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice. | 1992 | 12 |
| 14 | 2005 | 12 | |
| 15 | 2020 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2002 | 1 | |
| 19 | 2025 | 1 |
About Cécile Chartier
Cécile Chartier is a scholar working on Oncology, Genetics, Immunology, Genetics and Hematology, having authored 19 papers that have together received 2.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (6 papers), Immunotherapy and Immune Responses (5 papers), Wnt/β-catenin signaling in development and cancer (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), T-cell and B-cell Immunology (2 papers), Erythropoietin and Anemia Treatment (1 paper) and Polyomavirus and related diseases (1 paper). The work is most often cited by research in Oncology (917 citations), Genetics (710 citations), Molecular Biology (748 citations), Immunology (169 citations) and Cancer Research (87 citations). Cécile Chartier has collaborated with scholars based in United States and France. Frequent co-authors include Annick Dieterle, Andréa Pavirani, Majid Mehtali, Eric Degryse, Murielle Gantzer, John A. Lewicki, Austin L. Gurney, Michael F. Clarke, Tim Hoey and Stephanie Smith‐Berdan. Their work appears in journals such as Annals of Oncology, PLoS ONE, Clinical Cancer Research, Nature Medicine and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.